Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat
Steno Diabetes Center Grønland (Inuunerissaavik Steno) is a publicly funded healthcare and research institution, embedded in Greenland's healthcare system, that delivers specialized diabetes, COPD, and hypertension care alongside population-scale research and education for Greenland's Inuit population.
- Company typePrivate
- Founded2020
- HeadquartersNuuk, Greenland
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat does
Steno Diabetes Center Grønland (Inuunerissaavik Steno / Inuunerissaavik Steno Kalaallit Nunaat) is a publicly funded specialized healthcare and research institution established in 2020 and embedded within the Greenlandic Healthcare System (Det Grønlandske Sundhedsvæsen). Headquartered within Dronning Ingrids Sundhedscenter in Nuuk, with 19 employees, it operates as the sole specialized diabetes, COPD, and hypertension center in Greenland, serving the country's Inuit population of roughly 56,000 across dispersed towns and settlements. Its core offering integrates clinical services (diabetes management across Type 1, Type 2, MODY, and gestational; COPD pulmonary care; hypertension monitoring), patient education (the Inuunerissarfik Café launched in 2012, dietary guidelines, inhalation and blood-pressure video guidance, smoking cessation), and population-scale research (five national health surveys from 1993–2018; over 300 publications; Inuit-specific genetic and epidemiological studies; diabetic retinopathy, neuropathy, and sleep apnea research).
The center's underlying technology stack includes real-time electronic patient journal (EPJ) data from the national healthcare system, telemedicine-enabled portable OSA diagnostics, video-based home blood pressure guidance, a nationwide user panel managed via SurveyMonkey, and one in-house AI computer-vision model for diabetic retinopathy grading trained on Inuit-specific data (currently not clinically deployable due to insufficient accuracy). Research collaborations span Aarhus University, the University of Copenhagen, Ilisimatusarfik, and the broader network of seven Steno Diabetes Centres across Denmark, the Faroe Islands, and Greenland. Distribution combines a Nuuk-based specialty clinic, local lifestyle clinics in regional hospitals, an online booking portal (doktor.gl), mobile outreach visits to remote settlements, and telemedicine.
SDCG has no commercial revenue: it is government-owned, financed through public healthcare budgets and Steno Diabetes Center grant frameworks, and provides all patient-facing services at no direct cost to citizens. It is one of seven Steno Diabetes Centres operating across Denmark and the Faroe Islands and is led by Professor Marit Eika Jørgensen (appointed April 2024), alongside medical director Professor Michael Lynge Pedersen.
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat firmographics
Firmographics- Name
- Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat
- Legal name
- Inuunerissaavik Steno / Steno Diabetes Center Grønland
- Website
- https://steno.gl
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Steno Diabetes Center Grønland (Inuunerissaavik Steno) is a publicly funded healthcare and research institution, embedded in Greenland's healthcare system, that delivers specialized diabetes, COPD, and hypertension care alongside population-scale research and education for Greenland's Inuit population.
- Ownership category
- akta.pro rank
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat industry classification
Industry- Product category
- Diabetes Care Services
- NAICS
- Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Type 1 Diabetes Care (HLAKADAB)
- akta.pro secondary industries
- Hypertension & Kidney-Related Blood Pressure Clinics (HLAKAHAF), Diabetes Education & Insulin Management (Home-Based) (HSABACAJ)
Keywords
Where Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat is headquartered
LocationHeadquarters
- HQ city
- Nuuk
- HQ country
- Greenland
Offices1 record
Markets served
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Public Healthcare Funding: SDCG is a publicly funded institution operating as part of the Greenlandic Healthcare System (Det Grønlandske Sundhedsvæsen). Healthcare services are provided at no direct cost to citizens. The center is financed through government healthcare budgets and Steno Diabetes Center grant frameworks.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat product offering
Product offeringCore offering
Steno Diabetes Center Grønland delivers specialized clinical care, patient education, and population health research for diabetes, COPD, and hypertension across Greenland. The center is publicly funded and operates as part of the Greenlandic Healthcare System, providing services at no direct cost to citizens through its Nuuk facility, local lifestyle clinics, telemedicine, and mobile outreach visits to remote settlements.
Product overview
Steno Diabetes Center Grønland (Inuunerissaavik Steno) is a healthcare and research institution focused on chronic lifestyle diseases in Greenland. The organization operates as a single integrated offering combining clinical services (diabetes, COPD, hypertension management), patient education (Inuunerissarfik Café, user panel), and research (population surveys, diabetic complications, genetic studies). Key products include diabetic neuropathy and retinopathy screening, sleep apnea services, lifestyle counseling through the Lifestyle Café, and extensive research publications. The center also provides educational resources on nutrition, physical activity, and smoking cessation.
Differentiator
Problem solved
Functional benefit
Products and services
- Diabetes Care Services Comprehensive diabetes management covering Type 1, Type 2, MODY, and gestational diabetes, including treatment, follow-up care, diabetes control visits, and complications screening for individuals diagnosed with diabetes in Greenland.
- COPD/KOL Management Chronic Obstructive Pulmonary Disease management including lung function testing, inhalation medication management, pulmonary rehabilitation, and smoking cessation support for individuals diagnosed with COPD in Greenland.
- Hypertension Services High blood pressure diagnosis, monitoring, and treatment including home blood pressure measurement guidance and cardiovascular risk reduction counseling for individuals with elevated blood pressure in Greenland.
- Inuunerissarfik Café (Lifestyle Café) Group lifestyle counseling program offering health measurements (BMI, blood pressure, glucose, lung function) and lifestyle consultations for adults (18+) with or at risk of diabetes, hypertension, and COPD, held at Dronning Ingrids Sundhedscenter in Nuuk.
- Diabetic Retinopathy Screening Eye screening for diabetic retinopathy using the International Clinical Diabetic Retinopathy (ICDR) severity scale (Grade 0–4), supported by a population-specific AI grading model developed for Greenlandic Inuit, to detect and treat eye disease early and prevent blindness.
- Sleep Apnea (OSA) Services Obstructive Sleep Apnea diagnosis and treatment for type 2 diabetes and obesity patients in Greenland, including CPAP therapy initiation and follow-up via both conventional and telemedicine methods using portable diagnostic equipment.
Quantifiable outcome
- ~9% adult diabetes prevalence documented and monitored through population surveys since 1993
- +2 more outcomes
Companies that use Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat
Customer profileSegments5 records
Ideal customer profiles2 records
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability2 records
Feature3 records
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Steno Diabetes Center AarhuscoreJoint research collaboration on diabetic neuropathy in Greenland, conducted as part of a PhD project (Marie Mathilde Bjerg Christensen, Aarhus University). The study used population survey data from 2018 and electronic patient records to investigate the high incidence of diabetic neuropathy among Greenlanders, including those with prediabetes.
- Steno Diabetes Center CopenhagencoreCollaborating institution in the joint diabetic neuropathy study alongside SDCG and Steno Diabetes Center Aarhus. The collaboration aims to identify factors affecting nerve function in Greenlanders with diabetes and develop prevention strategies.
- Aarhus UniversitycoreAcademic partner institution. Multiple researchers hold joint affiliations between SDCG and Aarhus University, including PhD students and senior researchers working on population health, genetics, and clinical research in Greenland.
- Ilisimatusarfik (University of Greenland)coreThe national university of Greenland. Several SDCG researchers hold joint appointments with Ilisimatusarfik, and the university provides academic oversight for PhD students enrolled in Greenland-based research programs.
- University of CopenhagenminorAcademic partner institution. Researcher Marit Eika Jørgensen holds academic credentials from the University of Copenhagen, and the institution collaborates on diabetes epidemiology research involving Greenlandic populations.
- Steno Diabetes Center (all seven centers across Denmark and Faroe Islands)coreSDCG is one of seven Steno Diabetes Centres operating across Denmark and the Faroe Islands, sharing resources, research insights, and collaborative projects. The 'Diabetesforskerne' podcast series is a joint production across all seven centers. Collaboration includes shared research methodologies, quality standards, and professional development.
- Det Grønlandske Sundhedsvæsen (Greenlandic Healthcare System)coreSDCG is organizationally embedded within the Greenlandic Healthcare System. The center utilizes real-time health data from the electronic patient journal (EPJ) system and operates under the regulatory and ethical oversight of the Greenlandic health authorities for all research activities.
- Danish Diabetes Association (Diabetesforeningen)minorPartner organization providing additional resources, information, and support for people with diabetes in Greenland. Listed as a linked resource on SDCG's website alongside the Danish Heart Association and Danish Lung Association.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat competitors and assessment
Company assessmentEmerging players
- Canadian North Diabetes Research Network: Research collaborations studying diabetes and metabolic disease in Indigenous and Arctic populations in Canada. Comparable in addressing diabetes prevalence in geographically dispersed Inuit/Indigenous communities, though operating as a research network rather than a clinical center.
Direct peers
- Steno Diabetes Center Faroe Islands: Steno center serving the Faroe Islands — another small North Atlantic population with shared Inuit/Nordic heritage. Comparable in scale and mission, focused on diabetes care and research in a small island population.
- Steno Diabetes Center Aarhus: Danish Steno Diabetes Center collaborating with SDCG on the diabetic neuropathy study in Greenland. Closely comparable as a regional Steno center providing specialized diabetes care and population-based research in a defined geographic catchment.
- Steno Diabetes Center Copenhagen: The flagship Steno Diabetes Center in Denmark, focused on diabetes research, clinical care, and patient education. Directly comparable as a sister center operating under the same Steno Diabetes Center framework with shared research methodologies and the joint 'Diabetesforskerne' podcast.
Regional players
- Greenland Institute of Natural Resources (GINR/Naalisagaqarfik): Greenlandic public research institute covering health-relevant environmental, dietary, and population research. Comparable as a Greenland-embedded public research entity conducting studies relevant to Inuit health and environmental exposures.
- Nunavut Tunngavik Incorporated Health Programs: Inuit organization representing Inuit in Nunavut, Canada, with health and wellness programming for Inuit populations. Comparable as a population-health-focused organization serving Arctic Inuit communities with high diabetes burden.
Broad incumbents
- Statens Serum Institut: Danish public health institute that conducts population health surveillance and epidemiological research. Comparable in its role in chronic disease epidemiology and population survey work, though with a much broader infectious and public health mandate.
- Novo Nordisk Foundation Center for Basic Metabolic Research: Copenhagen-based academic research center conducting large-scale metabolic and diabetes research. Comparable as a major regional research entity in diabetes and metabolic disease, though operating at a much larger scale and academic rather than clinical-care focus.
Others
- Danish Diabetes Association (Diabetesforeningen): Listed partner and linked resource on SDCG's website. Comparable as a patient-facing diabetes advocacy and education organization in Denmark, providing resources that overlap with SDCG's patient education mission.
- Ilisimatusarfik (University of Greenland): The national university of Greenland and a core academic partner of SDCG. Comparable in its role in training PhD students and conducting research on Greenlandic populations, though focused on broader academic disciplines rather than diabetes specifically.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat social profiles
Digital presenceSteno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat financial estimates
Financial estimateRevenue estimate
Valuation estimate
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat leadership team
Management profileNumber of profiles
Profiles2 records
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat
What does Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat do?
Steno Diabetes Center Grønland delivers specialized clinical care, patient education, and population health research for diabetes, COPD, and hypertension across Greenland. The center is publicly funded and operates as part of the Greenlandic Healthcare System, providing services at no direct cost to citizens through its Nuuk facility, local lifestyle clinics, telemedicine, and mobile outreach visits to remote settlements.
Is Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat a public or private company?
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat is a private company. It is classified as state government owned and is currently operating.
When was Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat founded?
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat was founded in 2020. It employs 11 to 50 people.
Where is Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat based?
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat is headquartered in Nuuk, Greenland.
How does Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat make money?
One revenue line is on record: public Healthcare Funding.
Who are Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat's main competitors?
Canadian North Diabetes Research Network is listed as an emerging player. Direct peers are Steno Diabetes Center Faroe Islands, Steno Diabetes Center Aarhus and Steno Diabetes Center Copenhagen. Regional players are Greenland Institute of Natural Resources (GINR/Naalisagaqarfik) and Nunavut Tunngavik Incorporated Health Programs. Broad incumbents are Statens Serum Institut and Novo Nordisk Foundation Center for Basic Metabolic Research. Others are Danish Diabetes Association (Diabetesforeningen) and Ilisimatusarfik (University of Greenland).
Does Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat have an API?
No public API is recorded for Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat.
What industry is Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat in?
Steno Diabetes Center Grønland / Inuunerissaavik Steno Kalaallit Nunaat's product category is Diabetes Care Services. Its primary akta.pro industry code is HLAKADAB, Type 1 Diabetes Care, with a secondary code of HLAKAHAF, Hypertension & Kidney-Related Blood Pressure Clinics. Its NAICS code is 62111 and its SIC code is 8011.